ZNTL
Zentalis Pharmaceuticals Inc.
Company Overview
| Mkt Cap | $109.65M | Price | $1.50 |
| Volume | 428.00K | Change | +1.01% |
| P/E Ratio | -0.7 | Open | $1.46 |
| Revenue | $67.4M | Prev Close | $1.49 |
| Net Income | $-165.8M | 52W Range | $1.01 - $4.44 |
| Div Yield | N/A | Target | $5.74 |
| Overall | 38 | Value | 60 |
| Quality | 31 | Technical | 25 |
No chart data available
Stock Overview
Updated DailyZentalis Pharmaceuticals Inc. (ZNTL) is a leading Manufacturing company in the Pharmaceutical Preparation Manufacturing industry, currently trading at $1.50 with a market capitalization of $109.65 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows ZNTL with a volume of 428K shares. The stock opened down 1.68% from yesterday's close of $1.49. Current analyst estimates project earnings of $-1.99 per share for this year, with next year targeting $-1.83.
ZNTL demonstrates neutral technical outlook based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including OMHE, OILS-CA, OGN, ONPH.
Key investment considerations for ZNTL include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 282.7%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 2, 2025 at 06:38 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ZNTL | $1.50 | +1.0% | 428.00K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Zentalis Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW